{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:09Z","timestamp":1792788489076,"version":"4.5.0"},"reference-count":139,"publisher":"The Company of Biologists","issue":"9","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institutes of Health","award":["HG200399"],"award-info":[{"award-number":["HG200399"]}]},{"name":"National Institutes of Health","award":["AG000311"],"award-info":[{"award-number":["AG000311"]}]},{"name":"National Science Foundation","award":["CCF-1934553"],"award-info":[{"award-number":["CCF-1934553"]}]},{"name":"National Human Genome Research Institute","id":[{"id":"https:\/\/ror.org\/00baak391","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Down syndrome (DS) results from trisomy for human chromosome 21 and is the most frequent genetic cause of intellectual disability. No effective treatments currently exist that improve neurodevelopment and cognition. Atypical brain development in individuals with DS is apparent before birth, which suggests that the optimal time to begin administration of therapies is prenatally. Human neural progenitor cell (NPC) cultures provide a tractable in vitro model system to examine the effects of trisomy 21 (T21) on neurodevelopment and to measure the effects of pharmacological interventions. Here, we report the results of preclinical studies evaluating 24 candidate therapies. RNA sequencing analyses found that euploid and T21 NPCs showed different transcriptomic responses to five candidate pharmacotherapies. The Rho-associated coiled-coil kinase inhibitor fasudil increased proliferation of T21 NPCs, reduced expression of inflammatory pathway genes in T21 NPCs, and reduced markers of inflammation in LPS-stimulated microglial model systems. These results demonstrate that fasudil can alter multiple T21-associated abnormalities in a beneficial manner, suggesting that fasudil warrants further study as a candidate prenatal pharmacotherapy for DS.<\/jats:p>","DOI":"10.1242\/bio.062807","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:16:15Z","timestamp":1787642175000},"source":"Crossref","is-referenced-by-count":0,"title":["Fasudil induces anti-inflammatory transcriptomic changes and increased proliferation in human trisomy 21 neural progenitor cells"],"prefix":"10.1242","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7941-1088","authenticated-orcid":false,"given":"Laura L.","family":"Baxter","sequence":"first","affiliation":[{"name":"National Human Genome Research Institute, National Institutes of Health 1 Center for Precision Health Research, Prenatal Genomics and Therapy Section , , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Lee","sequence":"additional","affiliation":[{"name":"National Human Genome Research Institute, National Institutes of Health 1 Center for Precision Health Research, Prenatal Genomics and Therapy Section , , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Fuentes","sequence":"additional","affiliation":[{"name":"National Human Genome Research Institute, National Institutes of Health 1 Center for Precision Health Research, Prenatal Genomics and Therapy Section , , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman A.","family":"Mosley","sequence":"additional","affiliation":[{"name":"National Human Genome Research Institute, National Institutes of Health 1 Center for Precision Health Research, Prenatal Genomics and Therapy Section , , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Raymond","sequence":"additional","affiliation":[{"name":"National Human Genome Research Institute, National Institutes of Health 1 Center for Precision Health Research, Prenatal Genomics and Therapy Section , , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8847-1119","authenticated-orcid":false,"given":"Faycal","family":"Guedj","sequence":"additional","affiliation":[{"name":"National Human Genome Research Institute, National Institutes of Health 1 Center for Precision Health Research, Prenatal Genomics and Therapy Section , , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhou","sequence":"additional","affiliation":[{"name":"Tufts University 2 Department of Computer Science , , Medford, MA 02155 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna K.","family":"Slonim","sequence":"additional","affiliation":[{"name":"Tufts University 2 Department of Computer Science , , Medford, MA 02155 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot J.","family":"Glotfelty","sequence":"additional","affiliation":[{"name":", National Institute on Drug Abuse, National Institutes of Health 3 Cellular Stress and Inflammation Section, Intramural Research Program , Baltimore, MD 21224 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Tweedie","sequence":"additional","affiliation":[{"name":"National Institute on Aging, National Institutes of Health 4 Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program , , Baltimore, MD 21224 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel H.","family":"Greig","sequence":"additional","affiliation":[{"name":"National Institute on Aging, National Institutes of Health 4 Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program , , Baltimore, MD 21224 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana W.","family":"Bianchi","sequence":"additional","affiliation":[{"name":"National Human Genome Research Institute, National Institutes of Health 1 Center for Precision Health Research, Prenatal Genomics and Therapy Section , , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"2026101409264453400_BIO062807C1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/mnfr.201500781","article-title":"Differential effects of","volume":"60","author":"Abeysekera","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"2026101409264453400_BIO062807C2","doi-asserted-by":"publisher","first-page":"e22944","DOI":"10.1096\/fj.202202111RR","article-title":"Basal forebrain cholinergic neurons are vulnerable in a mouse model of Down syndrome and their molecular fingerprint is rescued by maternal choline supplementation","volume":"37","author":"Alldred","year":"2023","journal-title":"FASEB J."},{"key":"2026101409264453400_BIO062807C3","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3390\/biom15081131","article-title":"Benefits of maternal choline supplementation on aged basal forebrain cholinergic neurons (BFCNs) in a mouse model of Down syndrome and Alzheimer's disease","volume":"15","author":"Alldred","year":"2025","journal-title":"Biomolecules"},{"key":"2026101409264453400_BIO062807C4","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.biopsych.2025.10.023","article-title":"Neuroimmune mechanisms of neurodevelopmental disorders","volume":"99","author":"Anderson","year":"2025","journal-title":"Biol. Psychiatry"},{"key":"2026101409264453400_BIO062807C5","doi-asserted-by":"publisher","first-page":"629279","DOI":"10.3389\/fncel.2021.629279","article-title":"Validation of induced microglia-like cells (iMG","volume":"15","author":"Banerjee","year":"2021","journal-title":"Front. Cell Neurosci."},{"key":"2026101409264453400_BIO062807C6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/jdb4040035","article-title":"The many hats of Sonic Hedgehog signaling in nervous system development and disease","volume":"4","author":"Belgacem","year":"2016","journal-title":"J. Dev. Biol."},{"key":"2026101409264453400_BIO062807C7","doi-asserted-by":"publisher","first-page":"8769","DOI":"10.1523\/JNEUROSCI.0534-10.2010","article-title":"Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome","volume":"30","author":"Bianchi","year":"2010","journal-title":"J. Neurosci."},{"key":"2026101409264453400_BIO062807C8","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.1093\/hmg\/ddv284","article-title":"Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using genetic and therapeutic modulation of trisomic Dyrk1a","volume":"24","author":"Blazek","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"2026101409264453400_BIO062807C9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/stem.1297","article-title":"Integration-free induced pluripotent stem cells model genetic and neural developmental features of","volume":"31","author":"Briggs","year":"2013","journal-title":"Stem Cells"},{"key":"2026101409264453400_BIO062807C10","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/378776a0","article-title":"Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro","volume":"378","author":"Busciglio","year":"1995","journal-title":"Nature"},{"key":"2026101409264453400_BIO062807C11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ejphar.2012.05.040","article-title":"Prenatal fasudil exposure alleviates fetal growth but programs hyperphagia and overweight in the adult male rat","volume":"689","author":"Butruille","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"2026101409264453400_BIO062807C12","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3390\/molecules30030654","article-title":"Epigallocatechin","volume":"30","author":"Capasso","year":"2025","journal-title":"Molecules"},{"key":"2026101409264453400_BIO062807C13","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3389\/fnbeh.2015.00330","article-title":"Principal component analysis of the effects of environmental enrichment and (","volume":"9","author":"Catuara-Solarz","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"2026101409264453400_BIO062807C14","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41592-021-01126-2","article-title":"A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cells","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Methods"},{"key":"2026101409264453400_BIO062807C15","doi-asserted-by":"publisher","first-page":"10.53941\/ijddp.2025.100018","DOI":"10.53941\/ijddp.2025.100018","article-title":"Rho\/ROCK pathway as a therapeutic target in multiple diseases","volume":"4","author":"Cheng","year":"2025","journal-title":"Int. J. Drug Discov. Pharm."},{"key":"2026101409264453400_BIO062807C16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fnmol.2017.00261","article-title":"Regulation of microglia and macrophage polarization via apoptosis signal-regulating kinase 1 silencing after ischemic\/hypoxic injury","volume":"10","author":"Cheon","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"2026101409264453400_BIO062807C17","doi-asserted-by":"publisher","first-page":"107012","DOI":"10.1016\/j.isci.2023.107012","article-title":"Interferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signaling","volume":"26","author":"Chi","year":"2023","journal-title":"iScience"},{"key":"2026101409264453400_BIO062807C18","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.gim.2022.06.011","article-title":"Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study)","volume":"24","author":"Cieuta-Walti","year":"2022","journal-title":"Genet. Med."},{"key":"2026101409264453400_BIO062807C19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/hipo.20308","article-title":"Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice","volume":"17","author":"Contestabile","year":"2007","journal-title":"Hippocampus"},{"key":"2026101409264453400_BIO062807C20","doi-asserted-by":"publisher","first-page":"201ra120","DOI":"10.1126\/scitranslmed.3005983","article-title":"Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model","volume":"5","author":"Das","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"2026101409264453400_BIO062807C21","first-page":"263","article-title":"Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome","volume":"360","author":"Davisson","year":"1990","journal-title":"Prog. Clin. Biol. Res."},{"key":"2026101409264453400_BIO062807C22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/mnfr.201300325","article-title":"Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans","volume":"58","author":"De la Torre","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"2026101409264453400_BIO062807C23","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S1474-4422(16)30034-5","article-title":"Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"15","author":"de la Torre","year":"2016","journal-title":"Lancet Neurol."},{"key":"2026101409264453400_BIO062807C24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s00335-011-9356-0","article-title":"Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome","volume":"22","author":"Duchon","year":"2011","journal-title":"Mamm. Genome"},{"key":"2026101409264453400_BIO062807C25","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1021\/acs.jmedchem.5b00683","article-title":"Rho Kinase (ROCK) inhibitors and their therapeutic potential","volume":"59","author":"Feng","year":"2016","journal-title":"J. Med. Chem."},{"key":"2026101409264453400_BIO062807C26","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1093\/brain\/awaa326","article-title":"Evolution of neuroinflammation across the lifespan of individuals with Down syndrome","volume":"143","author":"Flores-Aguilar","year":"2020","journal-title":"Brain"},{"key":"2026101409264453400_BIO062807C27","doi-asserted-by":"publisher","first-page":"eadg6218","DOI":"10.1126\/sciadv.adg6218","article-title":"Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition","volume":"9","author":"Galbraith","year":"2023","journal-title":"Sci. Adv."},{"key":"2026101409264453400_BIO062807C28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s40478-021-01237-z","article-title":"Forebrain Shh overexpression improves cognitive function and locomotor hyperactivity in an aneuploid mouse model of Down syndrome and its euploid littermates","volume":"9","author":"Gao","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"2026101409264453400_BIO062807C29","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/jn\/nxaa074","article-title":"Prenatal administration of oleic acid or linolenic acid reduces neuromorphological and cognitive alterations in Ts65dn Down syndrome mice","volume":"150","author":"Garc\u00eda-Cerro","year":"2020","journal-title":"J. Nutr."},{"key":"2026101409264453400_BIO062807C30","doi-asserted-by":"publisher","first-page":"106332","DOI":"10.1016\/j.nbd.2023.106332","article-title":"Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease","volume":"188","author":"Gautier","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"2026101409264453400_BIO062807C31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neurobiolaging.2024.09.002","article-title":"Maternal choline supplementation rescues early endosome pathology in basal forebrain cholinergic neurons in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease","volume":"144","author":"Gautier","year":"2024","journal-title":"Neurobiol. Aging"},{"key":"2026101409264453400_BIO062807C32","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s11011-022-00949-y","article-title":"Nobiletin prevents amyloid beta(1-40)-induced cognitive impairment via inhibition of neuroinflammation and oxidative\/nitrosative stress","volume":"37","author":"Ghasemi-Tarie","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"2026101409264453400_BIO062807C33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/antiox8060163","article-title":"Timing of treatment with the flavonoid 7,8-DHF critically impacts on its effects on learning and memory in the Ts65Dn mouse","volume":"8","author":"Giacomini","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"2026101409264453400_BIO062807C34","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3390\/cells12101367","article-title":"The RhoA-ROCK1\/ROCK2 pathway exacerbates inflammatory signaling in immortalized and primary microglia","volume":"12","author":"Glotfelty","year":"2023","journal-title":"Cells"},{"key":"2026101409264453400_BIO062807C35","doi-asserted-by":"publisher","first-page":"110475","DOI":"10.1016\/j.jbc.2025.110475","article-title":"The critical roles of bioactive sphingolipids in inflammation","volume":"301","author":"Gomez-Larrauri","year":"2025","journal-title":"J. Biol. Chem."},{"key":"2026101409264453400_BIO062807C36","doi-asserted-by":"publisher","first-page":"10426","DOI":"10.1038\/s41598-020-67133-z","article-title":"Evaluation of the therapeutic potential of","volume":"10","author":"Goodlett","year":"2020","journal-title":"Sci. Rep."},{"key":"2026101409264453400_BIO062807C37","doi-asserted-by":"publisher","first-page":"104104","DOI":"10.18632\/oncotarget.22017","article-title":"Fasudil attenuates soluble fms-like tyrosine kinase-1 (sFlt-1)-induced hypertension in pregnant mice through RhoA\/ROCK pathway","volume":"8","author":"Gu","year":"2017","journal-title":"Oncotarget"},{"key":"2026101409264453400_BIO062807C38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/GCO.0000000000000056","article-title":"Prenatal treatment of Down syndrome: a reality?","volume":"26","author":"Guedj","year":"2014","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"2026101409264453400_BIO062807C39","doi-asserted-by":"publisher","first-page":"32353","DOI":"10.1038\/srep32353","article-title":"An integrated human\/murine transcriptome and pathway approach to identify prenatal treatments for Down syndrome","volume":"6","author":"Guedj","year":"2016","journal-title":"Sci. Rep."},{"key":"2026101409264453400_BIO062807C40","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.ajhg.2020.10.001","article-title":"Apigenin as a candidate prenatal treatment for trisomy 21: effects in human amniocytes and the Ts1Cje mouse model","volume":"107","author":"Guedj","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"2026101409264453400_BIO062807C41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.biopsych.2023.02.012","article-title":"The impact of Mmu17 non-Hsa21 orthologous genes in the Ts65Dn mouse model of Down syndrome: the gold standard refuted","volume":"94","author":"Guedj","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"2026101409264453400_BIO062807C42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1750-3639.2007.00113.x","article-title":"Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome","volume":"18","author":"Guidi","year":"2008","journal-title":"Brain Pathol."},{"key":"2026101409264453400_BIO062807C43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1750-3639.2012.00624.x","article-title":"Early pharmacotherapy with fluoxetine rescues dendritic pathology in the Ts65Dn mouse model of","volume":"23","author":"Guidi","year":"2013","journal-title":"Brain Pathol."},{"key":"2026101409264453400_BIO062807C44","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/brain\/awt340","article-title":"Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model","volume":"137","author":"Guidi","year":"2014","journal-title":"Brain"},{"key":"2026101409264453400_BIO062807C45","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/bpa.12605","article-title":"Abnormal development of the inferior temporal region in fetuses with Down syndrome","volume":"28","author":"Guidi","year":"2018","journal-title":"Brain Pathol."},{"key":"2026101409264453400_BIO062807C46","doi-asserted-by":"publisher","first-page":"577284","DOI":"10.1016\/j.jneuroim.2020.577284","article-title":"Fasudil inhibits the activation of microglia and astrocytes of transgenic Alzheimer's disease mice via the downregulation of TLR4\/Myd88\/NF-kappaB pathway","volume":"346","author":"Guo","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"2026101409264453400_BIO062807C47","doi-asserted-by":"publisher","first-page":"467251","DOI":"10.1155\/2012\/467251","article-title":"Adult-onset fluoxetine treatment does not improve behavioral impairments and may have adverse effects on the Ts65Dn mouse model of Down syndrome","volume":"2012","author":"Heinen","year":"2012","journal-title":"Neural Plast."},{"key":"2026101409264453400_BIO062807C48","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/cns.12002","article-title":"Fasudil ameliorates disease progression in experimental autoimmune encephalomyelitis, acting possibly through antiinflammatory effect","volume":"18","author":"Hou","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"2026101409264453400_BIO062807C49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12929-025-01150-w","article-title":"Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegeneration","volume":"32","author":"Hsueh","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"2026101409264453400_BIO062807C50","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1038\/s41598-025-87314-y","article-title":"Dysregulation of REST and its target genes impacts the fate of neural progenitor cells in","volume":"15","author":"Huang","year":"2025","journal-title":"Sci. Rep."},{"key":"2026101409264453400_BIO062807C51","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.celrep.2019.10.059","article-title":"Suppressing aneuploidy-associated phenotypes improves the fitness of trisomy 21 cells","volume":"29","author":"Hwang","year":"2019","journal-title":"Cell Rep."},{"key":"2026101409264453400_BIO062807C52","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/hmg\/ddx016","article-title":"Metformin restores the mitochondrial network and reverses mitochondrial dysfunction in Down syndrome cells","volume":"26","author":"Izzo","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"2026101409264453400_BIO062807C53","doi-asserted-by":"publisher","first-page":"1343569","DOI":"10.3389\/fphar.2024.1343569","article-title":"A protein-miRNA biomic analysis approach to explore neuroprotective potential of nobiletin in human neural progenitor cells (hNPCs)","volume":"15","author":"Jahan","year":"2024","journal-title":"Front. Pharmacol."},{"key":"2026101409264453400_BIO062807C54","doi-asserted-by":"publisher","first-page":"e0264254","DOI":"10.1371\/journal.pone.0264254","article-title":"Increased dosage and treatment time of","volume":"17","author":"Jamal","year":"2022","journal-title":"PLoS ONE"},{"key":"2026101409264453400_BIO062807C55","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.stem.2022.06.007","article-title":"Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer's disease","volume":"29","author":"Jin","year":"2022","journal-title":"Cell Stem Cell"},{"key":"2026101409264453400_BIO062807C56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cels.2017.11.001","article-title":"The","volume":"6","author":"Keenan","year":"2018","journal-title":"Cell Syst."},{"key":"2026101409264453400_BIO062807C57","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/pd.6436","article-title":"Biometric magnetic resonance imaging analysis of fetal brain development in Down syndrome","volume":"43","author":"Kitano","year":"2023","journal-title":"Prenat. Diagn."},{"key":"2026101409264453400_BIO062807C58","doi-asserted-by":"publisher","first-page":"941855","DOI":"10.3389\/fncel.2022.941855","article-title":"Neurodevelopment in Down syndrome: concordance in humans and models","volume":"16","author":"Klein","year":"2022","journal-title":"Front. Cell Neurosci."},{"key":"2026101409264453400_BIO062807C59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.03.008","article-title":"ROCK inhibition in models of neurodegeneration and its potential for clinical translation","volume":"189","author":"Koch","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"2026101409264453400_BIO062807C60","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S1474-4422(24)00373-9","article-title":"Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"23","author":"Koch","year":"2024","journal-title":"Lancet Neurol."},{"key":"2026101409264453400_BIO062807C61","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/biom14070872","article-title":"Incretin-based multi-agonist peptides are neuroprotective and anti-inflammatory in cellular models of neurodegeneration","volume":"14","author":"Kopp","year":"2024","journal-title":"Biomolecules"},{"key":"2026101409264453400_BIO062807C62","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"2026101409264453400_BIO062807C63","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.cell.2024.01.012","article-title":"Microglia maintain structural integrity during fetal brain morphogenesis","volume":"187","author":"Lawrence","year":"2024","journal-title":"Cell"},{"key":"2026101409264453400_BIO062807C64","doi-asserted-by":"publisher","DOI":"10.1101\/2022.10.20.513071","article-title":"ROCK2 knockout improves proliferation rate in a cellular model of Down","author":"LeBlanc-Straceski","year":"2022","journal-title":"bioRxiv"},{"key":"2026101409264453400_BIO062807C65","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1002\/alz.12610","article-title":"Role of chronic neuroinflammation in neuroplasticity and cognitive function: a hypothesis","volume":"18","author":"Lecca","year":"2022","journal-title":"Alzheimers Dement."},{"key":"2026101409264453400_BIO062807C66","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/hmg\/ddae160","article-title":"Analysis of genotype effects and inter-individual variability in iPSC-derived trisomy 21 neural progenitor cells","volume":"34","author":"Lee","year":"2025","journal-title":"Hum. Mol. Genet."},{"key":"2026101409264453400_BIO062807C67","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jpeds.2018.05.022","article-title":"Patterns of dietary supplement use in children with Down syndrome","volume":"201","author":"Lewanda","year":"2018","journal-title":"J. Pediatr."},{"key":"2026101409264453400_BIO062807C68","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/jnc.15521","article-title":"The metabolite GLP-1 (9-36) is neuroprotective and anti-inflammatory in cellular models of neurodegeneration","volume":"159","author":"Li","year":"2021","journal-title":"J. Neurochem."},{"key":"2026101409264453400_BIO062807C69","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40360-022-00565-7","article-title":"ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS\/NF-kappaB pathway","volume":"23","author":"Liu","year":"2022","journal-title":"BMC Pharmacol. Toxicol."},{"key":"2026101409264453400_BIO062807C70","doi-asserted-by":"publisher","first-page":"105679","DOI":"10.1016\/j.neuint.2024.105679","article-title":"Early chronic fasudil treatment rescues hippocampal alterations in the Ts65Dn model for","volume":"174","author":"L\u00f3pez-Hidalgo","year":"2024","journal-title":"Neurochem. Int."},{"key":"2026101409264453400_BIO062807C71","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1093\/hmg\/dds052","article-title":"OLIG2 over-expression impairs proliferation of human Down syndrome neural progenitors","volume":"21","author":"Lu","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"2026101409264453400_BIO062807C72","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.3390\/nu14142880","article-title":"Fatty acids: a safe tool for improving neurodevelopmental alterations in Down syndrome?","volume":"14","author":"Martinez-Cue","year":"2022","journal-title":"Nutrients"},{"key":"2026101409264453400_BIO062807C73","doi-asserted-by":"publisher","first-page":"e12113","DOI":"10.1002\/dad2.12113","article-title":"Distribution of microglial phenotypes as a function of age and Alzheimer's disease neuropathology in the brains of people with Down syndrome","volume":"12","author":"Martini","year":"2020","journal-title":"Alzheimers Dement. (Amst)"},{"key":"2026101409264453400_BIO062807C74","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1093\/hmg\/ddw309","article-title":"Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome","volume":"25","author":"McElyea","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"2026101409264453400_BIO062807C75","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.stem.2021.12.002","article-title":"Down-syndrome-induced senescence disrupts the nuclear architecture of neural progenitors","volume":"29","author":"Meharena","year":"2022","journal-title":"Cell Stem Cell"},{"key":"2026101409264453400_BIO062807C76","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/s41590-023-01522-0","article-title":"Defining blood-induced microglia functions in neurodegeneration through multiomic profiling","volume":"24","author":"Mendiola","year":"2023","journal-title":"Nat. Immunol."},{"key":"2026101409264453400_BIO062807C77","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3389\/fgene.2019.00606","article-title":"Pioglitazone improves mitochondrial organization and bioenergetics in Down syndrome cells","volume":"10","author":"Mollo","year":"2019","journal-title":"Front. Genet."},{"key":"2026101409264453400_BIO062807C78","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1037\/a0019590","article-title":"Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome","volume":"124","author":"Moon","year":"2010","journal-title":"Behav. Neurosci."},{"key":"2026101409264453400_BIO062807C79","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.3390\/ijms20143380","article-title":"Potential benefits of nobiletin, a citrus flavonoid, against Alzheimer's Disease and Parkinson's disease","volume":"20","author":"Nakajima","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"2026101409264453400_BIO062807C80","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3390\/biom9110690","article-title":"On the neuroprotective effects of naringenin: pharmacological targets, signaling pathways, molecular mechanisms, and clinical perspective","volume":"9","author":"Nouri","year":"2019","journal-title":"Biomolecules"},{"key":"2026101409264453400_BIO062807C81","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/art.25063","article-title":"Inhibition of NF-kappaB signaling by fasudil as a potential therapeutic strategy for rheumatoid arthritis","volume":"62","author":"Okamoto","year":"2010","journal-title":"Arthritis. Rheum."},{"key":"2026101409264453400_BIO062807C82","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.neuron.2020.09.010","article-title":"Rescuing over-activated microglia restores cognitive performance in juvenile animals of the Dp(16) mouse model of Down syndrome","volume":"108","author":"Pinto","year":"2020","journal-title":"Neuron"},{"key":"2026101409264453400_BIO062807C83","doi-asserted-by":"publisher","first-page":"315.e311","DOI":"10.1016\/j.ajog.2025.04.054","article-title":"The fetal brain neurosonography in trisomy 21: the seagull sign and thinned subplate","volume":"233","author":"Pooh","year":"2025","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2026101409264453400_BIO062807C84","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.neuroscience.2016.11.001","article-title":"Maternal choline supplementation in a mouse model of Down syndrome: effects on attention and nucleus basalis\/substantia innominata neuron morphology in adult offspring","volume":"340","author":"Powers","year":"2017","journal-title":"Neuroscience"},{"key":"2026101409264453400_BIO062807C85","doi-asserted-by":"publisher","first-page":"723046","DOI":"10.3389\/fnagi.2021.723046","article-title":"Maternal choline supplementation as a potential therapy for Down syndrome: assessment of effects throughout the lifespan","volume":"13","author":"Powers","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"2026101409264453400_BIO062807C86","doi-asserted-by":"publisher","first-page":"RP99323","DOI":"10.7554\/eLife.99323","article-title":"JAK inhibition decreases the autoimmune burden in Down syndrome","volume":"13","author":"Rachubinski","year":"2024","journal-title":"eLife"},{"key":"2026101409264453400_BIO062807C87","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/ng1095-177","article-title":"A mouse model for Down syndrome exhibits learning and behaviour deficits","volume":"11","author":"Reeves","year":"1995","journal-title":"Nat. Genet."},{"key":"2026101409264453400_BIO062807C88","doi-asserted-by":"publisher","first-page":"eaea1549","DOI":"10.1126\/science.aea1549","article-title":"Molecular and cellular processes disrupted in the early postnatal Down syndrome prefrontal cortex","volume":"392","author":"Risgaard","year":"2026","journal-title":"Science"},{"key":"2026101409264453400_BIO062807C89","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1073\/pnas.0510750103","article-title":"Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome mice","volume":"103","author":"Roper","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2026101409264453400_BIO062807C90","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fnagi.2017.00094","article-title":"Modulation of microglial activity by Rho-Kinase (ROCK) inhibition as therapeutic strategy in Parkinson's disease and amyotrophic lateral sclerosis","volume":"9","author":"Roser","year":"2017","journal-title":"Front. Aging Neurosci"},{"key":"2026101409264453400_BIO062807C91","doi-asserted-by":"publisher","first-page":"106847","DOI":"10.1016\/j.phrs.2023.106847","article-title":"Small molecule protein kinase inhibitors approved by regulatory agencies outside of the United States","volume":"194","author":"Roskoski","year":"2023","journal-title":"Pharmacol. Res."},{"key":"2026101409264453400_BIO062807C92","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/bs.pbr.2019.10.001","article-title":"Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome","volume":"251","author":"Rueda","year":"2020","journal-title":"Prog. Brain Res."},{"key":"2026101409264453400_BIO062807C93","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1093\/jn\/nxaa207","article-title":"Prenatal, but not postnatal, curcumin administration rescues neuromorphological and cognitive alterations in Ts65Dn Down syndrome mice","volume":"150","author":"Rueda","year":"2020","journal-title":"J. Nutr."},{"key":"2026101409264453400_BIO062807C94","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41583-024-00866-2","article-title":"Consequences of trisomy 21 for brain development in Down syndrome","volume":"25","author":"Russo","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"key":"2026101409264453400_BIO062807C95","doi-asserted-by":"publisher","first-page":"6256","DOI":"10.1073\/pnas.95.11.6256","article-title":"Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities","volume":"95","author":"Sago","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2026101409264453400_BIO062807C96","doi-asserted-by":"publisher","first-page":"e0278289","DOI":"10.1371\/journal.pone.0278289","article-title":"Cell-specific imputation of drug connectivity mapping with incomplete data","volume":"18","author":"Sapashnik","year":"2023","journal-title":"PLoS ONE"},{"key":"2026101409264453400_BIO062807C97","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00005-022-00642-z","article-title":"Rho kinases in embryonic development and stem cell research","volume":"70","author":"Shi","year":"2022","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"2026101409264453400_BIO062807C98","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3171\/jns.1992.76.4.0571","article-title":"Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial","volume":"76","author":"Shibuya","year":"1992","journal-title":"J. Neurosurg."},{"key":"2026101409264453400_BIO062807C99","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/cns.12116","article-title":"Rho kinase inhibitor fasudil protects against beta-amyloid-induced hippocampal neurodegeneration in rats","volume":"19","author":"Song","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"2026101409264453400_BIO062807C100","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1038\/s41598-019-40328-9","article-title":"Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models","volume":"9","author":"Souchet","year":"2019","journal-title":"Sci. Rep."},{"key":"2026101409264453400_BIO062807C101","doi-asserted-by":"publisher","first-page":"903729","DOI":"10.3389\/fncel.2022.903729","article-title":"The challenging pathway of treatment for neurogenesis impairment in Down","volume":"16","author":"Stagni","year":"2022","journal-title":"Front. Cell Neurosci."},{"key":"2026101409264453400_BIO062807C102","doi-asserted-by":"publisher","first-page":"e61689","DOI":"10.1371\/journal.pone.0061689","article-title":"Pharmacotherapy with fluoxetine restores functional connectivity from the dentate gyrus to field CA3 in the Ts65Dn mouse model of","volume":"8","author":"Stagni","year":"2013","journal-title":"PLoS ONE"},{"key":"2026101409264453400_BIO062807C103","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fnbeh.2015.00265","article-title":"Timing of therapies for Down syndrome: the sooner, the better","volume":"9","author":"Stagni","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"2026101409264453400_BIO062807C104","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.nbd.2014.12.005","article-title":"Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice","volume":"74","author":"Stagni","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"2026101409264453400_BIO062807C105","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.neuroscience.2016.07.031","article-title":"Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome","volume":"333","author":"Stagni","year":"2016","journal-title":"Neuroscience"},{"key":"2026101409264453400_BIO062807C106","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.expneurol.2017.08.018","article-title":"A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS","volume":"298","author":"Stagni","year":"2017","journal-title":"Exp. Neurol."},{"key":"2026101409264453400_BIO062807C107","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2017.07.026","article-title":"Neurogenesis impairment: An early developmental defect in Down syndrome","volume":"114","author":"Stagni","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"2026101409264453400_BIO062807C108","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/bpa.12663","article-title":"Subicular hypotrophy in fetuses with Down syndrome and in the Ts65Dn model of Down syndrome","volume":"29","author":"Stagni","year":"2019","journal-title":"Brain Pathol."},{"key":"2026101409264453400_BIO062807C109","doi-asserted-by":"publisher","first-page":"105870","DOI":"10.1016\/j.clineuro.2020.105870","article-title":"Neuroanatomical alterations in higher-order thalamic nuclei of fetuses with Down syndrome","volume":"194","author":"Stagni","year":"2020","journal-title":"Clin. Neurol. Neurosurg."},{"key":"2026101409264453400_BIO062807C110","doi-asserted-by":"publisher","first-page":"6300","DOI":"10.1038\/s41598-021-85284-5","article-title":"The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome","volume":"11","author":"Stagni","year":"2021","journal-title":"Sci. Rep."},{"key":"2026101409264453400_BIO062807C111","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.1038\/s41598-021-83757-1","article-title":"Green tea extracts containing epigallocatechin-3-gallate modulate facial development in Down syndrome","volume":"11","author":"Starbuck","year":"2021","journal-title":"Sci. Rep."},{"key":"2026101409264453400_BIO062807C112","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.physbeh.2017.05.003","article-title":"Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes","volume":"177","author":"Stringer","year":"2017","journal-title":"Physiol. Behav."},{"key":"2026101409264453400_BIO062807C113","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"2026101409264453400_BIO062807C114","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.16220","article-title":"Trisomy 21 consistently activates the interferon response","volume":"5","author":"Sullivan","year":"2016","journal-title":"eLife"},{"key":"2026101409264453400_BIO062807C115","doi-asserted-by":"publisher","first-page":"14818","DOI":"10.1038\/s41598-017-13858-3","article-title":"Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation","volume":"7","author":"Sullivan","year":"2017","journal-title":"Sci. Rep."},{"key":"2026101409264453400_BIO062807C116","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/bph.12277","article-title":"Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis","volume":"170","author":"Takata","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"2026101409264453400_BIO062807C117","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.1158\/0008-5472.CAN-17-0049","article-title":"Aneuploid cell survival relies upon sphingolipid homeostasis","volume":"77","author":"Tang","year":"2017","journal-title":"Cancer Res."},{"key":"2026101409264453400_BIO062807C118","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/cercor\/bhz094","article-title":"Quantitative MRI analyses of regional brain growth in living fetuses with Down syndrome","volume":"30","author":"Tarui","year":"2020","journal-title":"Cereb. Cortex"},{"key":"2026101409264453400_BIO062807C119","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40478-025-02189-4","article-title":"Microglia drive synaptic and functional connectivity deficits in the Ts65Dn mouse model of Down syndrome by affecting inhibition","volume":"14","author":"Tiberi","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"2026101409264453400_BIO062807C120","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3390\/pharmaceutics17111366","article-title":"Cardiopulmonary and immune alterations in the Ts65Dn mouse model of Down syndrome and modulation by epigallocatechin-3-gallate-enriched green tea extract","volume":"17","author":"Tielemans","year":"2025","journal-title":"Pharmaceutics"},{"key":"2026101409264453400_BIO062807C121","doi-asserted-by":"publisher","first-page":"H1505","DOI":"10.1152\/ajpheart.00490.2008","article-title":"Fasudil inhibits the myogenic response in the fetal pulmonary circulation","volume":"295","author":"Tourneux","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2026101409264453400_BIO062807C122","doi-asserted-by":"publisher","first-page":"108407","DOI":"10.1016\/j.celrep.2020.108407","article-title":"JAK1 inhibition blocks lethal immune hypersensitivity in a mouse model of Down syndrome","volume":"33","author":"Tuttle","year":"2020","journal-title":"Cell Rep."},{"key":"2026101409264453400_BIO062807C123","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jneumeth.2009.06.034","article-title":"A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors","volume":"183","author":"Tweedie","year":"2009","journal-title":"J. Neurosci. Methods"},{"key":"2026101409264453400_BIO062807C124","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/1874091X01105010037","article-title":"Thalidomide analogues suppress lipopolysaccharide-induced synthesis of TNF-alpha and nitrite, an intermediate of nitric oxide, in a cellular model of inflammation","volume":"5","author":"Tweedie","year":"2011","journal-title":"Open Biochem. J."},{"key":"2026101409264453400_BIO062807C125","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/antiox11010062","article-title":"Impaired brain mitochondrial bioenergetics in the Ts65Dn mouse model of Down syndrome is restored by neonatal treatment with the polyphenol 7,8-dihydroxyflavone","volume":"11","author":"Valenti","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"2026101409264453400_BIO062807C126","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.nbd.2013.04.016","article-title":"Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome","volume":"58","author":"Velazquez","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"2026101409264453400_BIO062807C127","doi-asserted-by":"publisher","first-page":"eaea1259","DOI":"10.1126\/science.aea1259","article-title":"A single-cell multiomic analysis identifies molecular and gene-regulatory mechanisms dysregulated in developing Down syndrome neocortex","volume":"392","author":"Vuong","year":"2026","journal-title":"Science"},{"key":"2026101409264453400_BIO062807C128","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.4103\/1673-5374.335827","article-title":"Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases","volume":"17","author":"Wang","year":"2022","journal-title":"Neural Regen. Res."},{"key":"2026101409264453400_BIO062807C129","doi-asserted-by":"publisher","first-page":"1198129","DOI":"10.3389\/fgene.2023.1198129","article-title":"From neurodevelopment to neurodegeneration: utilizing human stem cell models to gain insight into Down syndrome","volume":"14","author":"Watson","year":"2023","journal-title":"Front. Genet."},{"key":"2026101409264453400_BIO062807C130","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/s41588-023-01399-7","article-title":"Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model","volume":"55","author":"Waugh","year":"2023","journal-title":"Nat. Genet."},{"key":"2026101409264453400_BIO062807C131","doi-asserted-by":"publisher","first-page":"1308577","DOI":"10.3389\/fnagi.2024.1308577","article-title":"Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson's disease (ROCK-PD)","volume":"16","author":"Wolff","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"2026101409264453400_BIO062807C132","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s40263-024-01070-7","article-title":"SAFE-ROCK: a phase I trial of an oral application of the ROCK inhibitor fasudil to assess bioavailability, safety, and tolerability in healthy participants","volume":"38","author":"Wolff","year":"2024","journal-title":"CNS Drugs"},{"key":"2026101409264453400_BIO062807C133","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.3390\/nu15092228","article-title":"Nobiletin mitigates D-galactose-induced memory impairment via improving hippocampal neurogenesis in mice","volume":"15","author":"Xiong","year":"2023","journal-title":"Nutrients"},{"key":"2026101409264453400_BIO062807C134","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3233\/JPD-191909","article-title":"Fasudil promotes alpha-synuclein clearance in an AAV-mediated alpha-synuclein rat model of Parkinson's disease by autophagy activation","volume":"10","author":"Yang","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"2026101409264453400_BIO062807C135","doi-asserted-by":"publisher","first-page":"1481983","DOI":"10.3389\/fnins.2024.1481983","article-title":"Role of Rho-associated kinases and their inhibitor fasudil in neurodegenerative diseases","volume":"18","author":"Ye","year":"2024","journal-title":"Front. Neurosci."},{"key":"2026101409264453400_BIO062807C136","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/cercor\/bhaa255","article-title":"Regional alterations in cortical sulcal depth in living fetuses with Down syndrome","volume":"31","author":"Yun","year":"2021","journal-title":"Cereb. Cortex"},{"key":"2026101409264453400_BIO062807C137","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2176\/nmc.46.421","article-title":"Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage","volume":"46","author":"Zhao","year":"2006","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"2026101409264453400_BIO062807C138","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"2026101409264453400_BIO062807C139","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.nutres.2015.02.007","article-title":"Fish oil improves gene targets of Down syndrome in C57BL and BALB\/c mice","volume":"35","author":"Zmijewski","year":"2015","journal-title":"Nutr. Res."}],"container-title":["Biology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.biologists.com\/bio\/article-pdf\/doi\/10.1242\/bio.062807\/3713420\/bio062807.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/bio\/article-pdf\/doi\/10.1242\/bio.062807\/3716097\/bio062807.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/bio\/article-pdf\/doi\/10.1242\/bio.062807\/3716097\/bio062807.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:26:54Z","timestamp":1791984414000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/bio\/article\/15\/9\/bio062807\/372822\/Fasudil-induces-anti-inflammatory-transcriptomic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":139,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,15]]}},"URL":"https:\/\/doi.org\/10.1242\/bio.062807","relation":{},"ISSN":["2046-6390"],"issn-type":[{"value":"2046-6390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"article-number":"bio062807"}}